ISCP 2021 - Contemporary role of Pharmacists as CV team members
ISCP 2021 - Stroke Prevention in Atrial Fibrillation: The Whole Person
ISCP 2021
ISCP 2021 - Inflammation and atherosclerosis- the missing therapeutic link
ISCP 2021 - Poised to take over the world in Heart Failure management?
ISCP 2021 - Henry N Neufield Lecture: Atrial Fibrillation: What does the future hold?
ISCP 2021 - The role of Telemedicine and Cardiovascular Pharmacotherapy
ISCP 2021 - Oral Presentation Competition
ISCP 2021 - Hypertension Updates: The low-downs on the pressures that clinicians face
ISCP 2021 - Interventional Pharmacology: Walking the tightrope of ischemia and bleeding
ISCP 2021 - DM management in CVD: Don’t throw the baby out with the bath water
ISCP 2021 - Closing Plenary: Pharmacotherapy decision-making: Does the Asian Paradox Exist?
ISCP 2021 Dapagliflozin et al. The growing therapeutic spectrum of SGLT2i
ISCP 2021 - Opening Plenary: Cardiovascular Implications of COVID-19
ISCP 2021 - Shall we now add SGLT2 inhibitors to our water?
ISCP 2021 - When your atria persist in fibrillation…
ISCP 2021 Opening Plenary: Cardiovascular Implications of COVID-19
ISCP 2021 Clinical Pharmacotherapy in hypercholesterolemia Targeting the Bad not forgetting the Ugly
New Learning Agreement Demo
ISCP 2021 New Vision Healthcare